Cashu | News | IONS

HomeWatchlistNewsSignalsPicks

DJI

-0.05%

SPX

+0.51%

IXIC

+1.02%

FTSE

+0.67%

N225

0.00%

AXJO

0.00%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Ionis Pharmaceuticals News

Stocks making the biggest midday moves: Frontier Group, Kraft Heinz, Biogen and more

Feature Image for interests on Breaking News: Markets, Business, Communication Services, Consumer Defensive from cnbc.com

Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

Feature Image for interests on Big Gainers, Financial Services, Healthcare, Industrials from benzinga.com

Ionis Pharma's Investigational Drug Shows Promise For Triglyceride And Pancreatitis Reduction

Feature Image for interests on Analyst Color, Biotech, Expert Ideas, Healthcare from benzinga.com

What's Going On With Takeda Stock On Friday?

Feature Image for interests on Biotech, Health Care, Healthcare, Large Cap from benzinga.com

Tharimmune (THAR) Shares Skyrocket On Promising Opioid Countermeasure Data

Feature Image for interests on Healthcare, News, Retail Investor Stocks, Stock from benzinga.com

Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder

Feature Image for interests on Biotech, Health Care, Healthcare, Large Cap from benzinga.com

IONS Premarket Gains 2.4% After C-Suite Insider Sells $440K In Stock

Feature Image for interests on Biotech, Equities, Financial Services, Healthcare from benzinga.com

Ionis Posts Surprise Q2 Profit, Double Revenues On Stronger Sales From Newly Approved Genetic Disease Drug

Feature Image for interests on Biotech, Earnings, Guidance, Healthcare from benzinga.com

about 1 month ago

An Overview of Ionis Pharmaceuticals's Earnings

about 1 month ago

Biogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis' Zolgensma

Feature Image for interests on Biotech, Briefs, Health Care, Healthcare from benzinga.com

Latest Cashu News

Ionis Pharmaceuticals: Thriving Amid Market Volatility in Biopharmaceutical Innovation

Ionis Pharmaceuticals' IONS Dawnzera Approved by FDA for Hereditary Angioedema Treatment

Ionis Pharmaceuticals Gains FDA Approval for IONS Dawnzera, a New HAE Treatment

Stocks

Health Care

ions

Ionis Pharmaceuticals

NASDAQ: IONS

+3.02 (+5.25%)

60.51

USD

At close at Sep 03, 20:41 UTC